MedTrace Logo

Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis

NCT02105818 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2017-04-13

No results posted yet for this study

Summary

The purpose of this study is the validation of a newly developed self-report questionnaire which aims at determining the prevalence, location and intensity of SWAllowing difficulties with drug intake, and describing the impact on MEdication regimen focusing on COping strategies (SWAMECO).

Conditions

  • Systemic Sclerosis
  • Deglutition Disorders
  • Adherence to Medication Regime
  • Coping Behaviour
  • Scleroderma, Systemic

Sponsors & Collaborators

  • University of Basel

    collaborator OTHER

  • Reha Rheinfelden

    collaborator OTHER

  • Kurt Hersberger

    lead OTHER

Principal Investigators

  • Kurt Hersberger, Prof · Pharmaceutical Care Research Group, University of Basel, Switzerland

  • Markus Messerli, MSc · Pharmaceutical Care Research Group, University of Basel, Switzerland

  • Michael Buslau, PD MD · Reha Rheinfelden, Switzerland

  • Rebecca Wysser, BSc · Pharmaceutical Care Research Group, University of Basel, Switzerland

  • Isabelle Arnet, PhD · Pharmaceutical Care Research Group, University of Basel, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-06-30
Completion
2014-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02105818 on ClinicalTrials.gov